Coronavirus: Chinese company signs deal to get access to appealing Oxford University vaccine

on
featured image

Five out of the six vaccines that are presently undergoing phase 3 human trials will be readily available in China. Photo: AFP

  • Shenzhen Kangtai Biological Products signs accrediting deal with AstraZeneca and hopes to produce 200 million dosages a year
  • Vaccine produced encouraging test leads to stage 2 trials by triggering an immune action amongst volunteers

Topic |.
Coronavirus pandemic

Zhuang Pinghui

Upgraded: 8: 53 pm, 8 Aug, 2020

Find Out More

https://covid19globalcases.com/coronavirus-chinese-company-signs-deal-to-get-access-to-appealing-oxford-university-vaccine/

Comments

Post a Comment